Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Shenqi balance Capsule in nonproliferative diabetic retinopathy
CTR20213082Phase 2Completed
- Sponsor
- 西安乐健生物科技
- Start
- Feb 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shenqi Balance Capsule in diabetic retinopathy (DR), sponsored by 西安乐健生物科技. Started Feb 2022; status: completed.
02
Drugs
Shenqi Balance Capsule
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on CTR20213082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213082.